Rapid molecular serotyping of salmonella: validation of the CTS 2.0 workflow for veterinary and food safety surveillance
Active Cooperative Agreement Awarded
- Award ID
- U18FD008899
- Recipient
-
University Of Wisconsin System UEI LCLSJAGTNZQ7
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $36,200
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 18% complete
- Funding agency
- Food and Drug Administration Department of Health and Human Services
- Place of performance
- Madison, WI 53715, USA
Award details come from USAspending.gov.
Description
- Abstract
- Rapid and accurate serotyping of salmonella is essential for effective outbreak detection, regulatory response, and antimicrobial resistance (AMR) surveillance in animal agriculture. This study aims to validate the check and trace salmonella (CTS) 2.0 molecular serotyping platform as a high-throughput, rapid alternative to traditional kauffmann and white scheme serotyping within the wisconsin veterinary diagnostic laboratory (WVDL) and the VET-lirn network. A 100-isolate validation panel representing high-consequence foodborne serovars, regionally important agricultural strains, monophasic and genetically complex variants, and non-salmonella controls will be used to rigorously assess assay performance. CTS 2.0 results will be benchmarked against historical phenotypic serotyping, with discordant findings resolved through whole-genome sequencing (WGS) and in-silico serotyping. An additional set of 100 isolates across diverse geographic regions with assigned genovar codes will be sequenced and benchmarked against WGS data to establish a reference dataset for interim use until corresponding updates are incorporated into the manufacturer's database. The study will evaluate key performance metrics including accuracy, turnaround time, and throughput during surge testing scenarios. Integration of WGS-based adjudication and AMR gene detection will further strengthen the interpretive framework for public health and regulatory decision-making. Successful validation will enable laboratories to transition from multi-day phenotypic workflows to a rapid molecular serotyping system capable of delivering actionable results within hours. This work directly supports VET-lirn priorities by advancing new diagnostic technologies for animal food safety and AMR monitoring, ultimately enhancing national outbreak response capacity and compliance with emerging USDA fsis salmonella control policies.
Quick answers
Who received award U18FD008899?
U18FD008899 was awarded to University Of Wisconsin System by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.
How much is award U18FD008899 worth?
$36,200 has been obligated on U18FD008899.
Which agency awarded U18FD008899?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008899, with funding from Food and Drug Administration (Department of Health and Human Services).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award